SEC Form 5

FORM 5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Form 3 Holdings Reported.

Form 4 Transactions Reported.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

OMB APPROVAL

Washington, D.C. 20549

OMB Number:

3235-0362

ANNUAL STATEMENT OF CHANGES IN BENEFICIAL

Estimated average burden

hours per response:

1.0

OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934

or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person *

STANGER KENT W

(Last)

(First)

(Middle)

1600 W MERIT PARKWAY

(Street)

SOUTH

UT

84095

JORDAN

2.

Issuer Name and Ticker or Trading Symbol

5. Relationship of Reporting Person(s) to Issuer

MERIT MEDICAL SYSTEMS INC[ MMSI

(Check all applicable)

]

X

Director

10% Owner

Officer (give title

Other (specify

3.

Statement for Issuer's Fiscal Year Ended (Month/Day/Year)

below)

below)

12/31/2019

4.

If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable

Line)

X Form filed by One Reporting Person

Form filed by More than One Reporting

Person

(City)(State)(Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1. Title of Security (Instr. 3)

2. Transaction

2A. Deemed

3.

4. Securities Acquired (A) or Disposed Of

5. Amount of

6.

7. Nature of

Date

Execution Date,

Transaction

(D) (Instr. 3, 4 and 5)

Securities

Ownership

Indirect

(Month/Day/Year)

if any

Code (Instr.

Beneficially

Form: Direct

Beneficial

(Month/Day/Year)

8)

(A) or

Owned at end of

(D) or

Ownership

Amount

Price

Issuer's Fiscal

Indirect (I)

(Instr. 4)

(D)

Year (Instr. 3 and

(Instr. 4)

4)

Common Stock, No Par Value

42,278

I

By 401(k)

plan(1)

Common Stock, No Par Value

4,271(2)

D

Family

Common Stock, No Par Value

29,524

I

Limited

Liability

Company(3)

Common Stock, No Par Value

10/30/2019

G(4)

2,769

D

$0

412,318

D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned

(e.g., puts, calls, warrants, options, convertible securities)

1. Title of

2.

3. Transaction

3A. Deemed

4.

5.

6. Date Exercisable and

7. Title and

8. Price

9. Number of

10.

11. Nature

Derivative

Conversion

Date

Execution Date,

Transaction

Number

Expiration Date

Amount of

of

derivative

Ownership

of Indirect

Security

or Exercise

(Month/Day/Year)

if any

Code (Instr.

of

(Month/Day/Year)

Securities

Derivative

Securities

Form:

Beneficial

(Instr. 3)

Price of

(Month/Day/Year)

8)

Derivative

Underlying

Security

Beneficially

Direct (D)

Ownership

Derivative

Securities

Derivative Security

(Instr. 5)

Owned

or Indirect

(Instr. 4)

Security

Acquired

(Instr. 3 and 4)

Following

(I) (Instr. 4)

(A) or

Reported

Disposed

Transaction(s)

of (D)

(Instr. 4)

(Instr. 3,

4 and 5)

Amount

or

Number

Date

Expiration

of

(A)

(D)

Exercisable

Date

Title

Shares

Non-

qualified

stock

$12.06

10/04/2015(5)

10/04/2021

Common

2,000

2,000

D

options

Stock

(right to

buy)

Non-

qualified

stock

$19.72

05/02/2017(6)

05/02/2023

Common

9,375

9,375

D

options

Stock

(right to

buy)

Non-

qualified

stock

$18.8

05/26/2017(7)

05/26/2023

Common

25,000

25,000

D

options

Stock

(right to

buy)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned

(e.g., puts, calls, warrants, options, convertible securities)

1. Title of

2.

3. Transaction

3A. Deemed

4.

5.

6. Date Exercisable and

7. Title and

8. Price

9. Number of

10.

11. Nature

Derivative

Conversion

Date

Execution Date,

Transaction

Number

Expiration Date

Amount of

of

derivative

Ownership

of Indirect

Security

or Exercise

(Month/Day/Year)

if any

Code (Instr.

of

(Month/Day/Year)

Securities

Derivative

Securities

Form:

Beneficial

(Instr. 3)

Price of

(Month/Day/Year)

8)

Derivative

Underlying

Security

Beneficially

Direct (D)

Ownership

Derivative

Securities

Derivative Security

(Instr. 5)

Owned

or Indirect

(Instr. 4)

Security

Acquired

(Instr. 3 and 4)

Following

(I) (Instr. 4)

(A) or

Reported

Disposed

Transaction(s)

of (D)

(Instr. 4)

(Instr. 3,

4 and 5)

Amount

or

Number

Date

Expiration

of

(A)

(D)

Exercisable

Date

Title

Shares

Non-

qualified

stock

$34.4

05/24/2018(8)

05/24/2024

Common

25,000

25,000

D

options

Stock

(right to

buy)

Non-

qualified

stock

$50.5

06/07/2019(9)

06/07/2025

Common

25,000

25,000

D

options

Stock

(right to

buy)

Non-

qualified

stock

$52.17

05/24/2020(10)

05/24/2026

Common

13,750

13,750

D

options

Stock

(right to

buy)

Non-

qualified

stock

$52.17

05/31/2020(11)

05/31/2026

Common

7,500

7,500

D

options

Stock

(right to

buy)

Explanation of Responses:

1. Represents plan holdings as of 01/22/2020.

2. Employee stock purchase plan holdings as of 01/22/2020.

3. This report shall not be deemed an admission that the reporting person is the beneficial owner of the securities held by K.W.S. Properties LC.

4. This is a gift.

5. Becomes exercisable in equal annual installments of 20% commencing on 10/04/2015.

6. Becomes exercisable in equal annual installments of 20% commencing on 05/02/2017.

7. Becomes exercisable in equal annual installments of 20% commencing on 05/26/2017.

8. Becomes exercisable in equal annual installments of 20% commencing on 05/24/2018.

9. Becomes exercisable in equal annual installments of 20% commencing on 06/07/2019.

10. Becomes exercisable in equal annual installments of 33% commencing on 05/24/2020.

11. Becomes exercisable in equal annual installments of 33% commencing on 05/31/2020.

Brian G. Lloyd, Attorney-in-

01/23/2020

Fact

** Signature of Reporting Person

Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

  • Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Attachments

  • Original document
  • Permalink

Disclaimer

Merit Medical Systems Inc. published this content on 23 January 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 January 2020 22:19:06 UTC